Cambridge, Massachusetts
United States
78
2016-06-23
40
2018-06-12
These are the the leading inventors for applications assigned to BIOGEN IDEC INC.:
BIOGEN IDEC INC. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Treatment of pemphigus
#2 | 2014-12-11USE OF CHIMERIC ANTI-CD20 ANTIBODY AS IN VITRO OR IN VIVO PURGING AGENT IN PATIENTS RECEIVING BMT OR PBSC TRANSPLANT
#3 | 2014-05-15TREATMENT OF MULTIPLE SCLEROSIS
#4 | 2014-02-27COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#5 | 2013-12-12TREATMENT OF PEMPHIGUS
#6 | 2013-10-17USE OF CHIMERIC ANTI-CD20 ANTIBODY AS IN VITRO OR IN VIVO PURGING AGENT IN PATIENTS RECEIVING BMT OR PBSC TRANSPLANT
#7 | 2013-07-18NON-FUCOSYLATED ANTIBODIES
#8 | 2012-09-20 ✅ Patent 9,198,955 granted on 2015-12-01Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
#9 | 2011-07-07USE OF CHIMERIC ANTI-CD20 ANTIBODY AS IN VITRO OR IN VIVO PURGING AGENT IN PATIENTS RECEIVING BMT OR PBSC TRANSPLANT
#10 | 2010-08-12MODULATION OF TUMOR MICROENVIRONMENT
#11 | 2010-07-29TREATMENT OF HODGKINS LYMPHOMA
#12 | 2010-06-29 ✅ Patent 7,744,877 granted on 2010-06-29Expression and use of anti-CD20 Antibodies
#13 | 2010-05-27Polymorphs and solvates of a pharmaceutical and method of making
#14 | 2010-04-01 ✅ Patent 8,206,711 granted on 2012-06-26Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
#15 | 2010-03-23 ✅ Patent 7,682,612 granted on 2010-03-23Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
#16 | 2010-01-07BLOCKING IMMUNE RESPONSE TO A GRAFT
#17 | 2009-09-10RECOMBINANT ANTI-CD4 ANTIBODIES FOR HUMAN THERAPY
#18 | 2009-09-03RECOMBINANT ANTI-CD4 ANTIBODIES FOR HUMAN THERAPY
#19 | 2009-05-14IDENTIFICATION OF UNIQUE BINDING INTERACTIONS BETWEEN CERTAIN ANTIBODIES AND THE HUMAN B7.1 AND B7.2 CO-STIMULATORY ANTIGENS
#20 | 2009-03-12 ✅ Patent 7,695,940 granted on 2010-04-13Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
#21 | 2009-03-05GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS
#22 | 2009-02-19Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
#23 | 2009-01-15GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS
#24 | 2009-01-08 ✅ Patent 7,510,713 granted on 2009-03-31Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodies
#25 | 2009-01-08 ✅ Patent 7,510,712 granted on 2009-03-31Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies
#26 | 2008-11-18 ✅ Patent 7,452,534 granted on 2008-11-18Recombinant anti-CD4 antibodies for human therapy
#27 | 2008-09-18IMMUNOREGULATORY ANTIBODIES AND USES THEREOF
#28 | 2008-09-18IMMUNOREGULATORY ANTIBODIES AND USES THEREOF
#29 | 2008-09-04USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#30 | 2008-09-04USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#31 | 2008-09-04USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#32 | 2008-09-04Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas
#33 | 2008-08-14GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS
#34 | 2008-07-17USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#35 | 2008-06-03 ✅ Patent 7,381,560 granted on 2008-06-03Expression and use of anti-CD20 antibodies
#36 | 2008-05-15 ✅ Patent 7,491,393 granted on 2009-02-17Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies
#37 | 2008-04-24 ✅ Patent 7,501,264 granted on 2009-03-10Methods of producing 7C10 and 16C10 CD80-specific antibodies
#38 | 2008-04-17 ✅ Patent 7,422,739 granted on 2008-09-09Anti-CD20 antibodies
#39 | 2008-03-04 ✅ Patent 7,338,658 granted on 2008-03-04Recombinant anti-CD4 antibodies for human therapy
#40 | 2008-02-14 ✅ Patent 7,414,123 granted on 2008-08-19Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
#41 | 2007-12-06 ✅ Patent 7,319,139 granted on 2008-01-15TAG-72 specific C2 domain deleted antibodies
#42 | 2007-11-22 ✅ Patent 7,759,117 granted on 2010-07-20Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures
#43 | 2007-06-26 ✅ Patent 7,235,360 granted on 2007-06-26Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
#44 | 2007-06-14Anti-mouse CD20 antibodies and uses thereof
#45 | 2007-06-07 ✅ Patent 7,417,128 granted on 2008-08-267C10 and 16C10 CD80-specific antibodies
#46 | 2007-05-22 ✅ Patent 7,220,356 granted on 2007-05-22Method of purifying polypeptides by simulated moving bed chromatography
#47 | 2007-04-12Neutralizing High Affinity Human Monoclonal Antibodies Specific to RSV F-Protein and Methods for their Manufacture and Therapeutic use thereof
#48 | 2007-03-27 ✅ Patent 7,195,750 granted on 2007-03-27Clinical parameters for determining hematologic toxicity prior to radioimmunotherapy
#49 | 2007-03-22ANTI-CD80 ANTIBODY HAVING ADCC ACTIVITY FOR ADCC MEDIATED KILLING OF B CELL LYMPHOMA CELLS ALONE OR IN COMBINATION WITH OTHER THERAPIES
#50 | 2007-02-13 ✅ Patent 7,175,847 granted on 2007-02-13Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80 binding to CTLA-4
#51 | 2007-01-11Immunoregulatory Antibodies and Uses Thereof
#52 | 2007-01-11Methods for treating fibrotic conditions
#53 | 2007-01-04COMBINATION THERAPY FOR TREATMENT OF AUTOIMMUNE DISEASES USING B- CELL DEPLETING/IMMUNOREGULATORY ANTIBODY COMBINATION
#54 | 2006-12-26 ✅ Patent 7,153,508 granted on 2006-12-26Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4
#55 | 2006-12-21Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
#56 | 2006-12-21Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
#57 | 2006-12-07 ✅ Patent 7,425,447 granted on 2008-09-16Host cells expressing 7C10 and 16C10 CD80-specific antibodies
#58 | 2006-12-07COMBINATION THERAPY FOR TREATMENT OF AUTOIMMUNE DISEASES USING B-CELL DEPLETING/IMMUNOREGULATORY ANTIBODY COMBINATION
#59 | 2006-10-17 ✅ Patent 7,122,187 granted on 2006-10-17Treating autoimmune diseases with humanized anti-CD40L antibody
#60 | 2006-10-10 ✅ Patent 7,118,924 granted on 2006-10-10Method for producing human antibodies in SCID mice which uses dendritic cells pulsed with antigen-antibody complexes and antigen-antibody complexes as immunizing agents
#61 | 2006-08-24 ✅ Patent 7,294,753 granted on 2007-11-13Method for preparing anti-MIF antibodies
#62 | 2006-08-03USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#63 | 2006-07-11 ✅ Patent 7,074,406 granted on 2006-07-11Treating allergic diseases with humanized anti-CD40L antibody
#64 | 2006-06-08Variant IgG3 RITUXAN and therapeutic uses thereof
#65 | 2006-04-04 ✅ Patent 7,022,686 granted on 2006-04-04A1 adenosine receptro antagonists
#66 | 2006-03-30 ✅ Patent 7,229,620 granted on 2007-06-12Method for radiolabeling antibodies with yttrium-90
#67 | 2006-02-14 ✅ Patent 6,998,125 granted on 2006-02-14Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
#68 | 2006-02-07 ✅ Patent 6,994,840 granted on 2006-02-07Kit for radiolabeling ligands with yttrium-90
#69 | 2005-11-24 ✅ Patent 7,192,585 granted on 2007-03-20CD80 specific antibodies
#70 | 2005-11-17 ✅ Patent 7,582,299 granted on 2009-09-01Cripto-specific antibodies
#71 | 2005-10-18 ✅ Patent 6,955,810 granted on 2005-10-18Method for the treatment of inflammatory disorders
#72 | 2005-10-13 ✅ Patent 7,462,353 granted on 2008-12-09Method for the treatment of inflammatory disorders
#73 | 2005-09-15Type II TGF-beta receptor/immunoglobulin constant region fusion proteins
#74 | 2005-06-16 ✅ Patent 7,323,170 granted on 2008-01-29Anti-CD80 antibodies
#75 | 2005-06-02Hydrophobically-modified protein compositions and methods
#76 | 2005-05-24 ✅ Patent 6,897,297 granted on 2005-05-24Hydrophobically-modified protein compositions and methods
#77 | 2005-03-10 ✅ Patent 7,332,163 granted on 2008-02-19Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
#78 | 2005-02-17 ✅ Patent 7,157,276 granted on 2007-01-02Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures
30710 ⎘